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June Supplement 201190S Abstractsinduced atherosclerotic change characterized by the histo-
logic presence of foamy macrophages and cholesterol clefts
had been fully attenuated by the chronic presence of
everolimus.
Conclusions: In this experimental animal model, long-
term local arterial stent-mediated delivery of everolimus
inhibited the formation of early neointimal hyperplasia and
atherosclerosis.
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Mitsuhiro Yamamaura, Yuji Miyamoto, MasatakaMitsuno,
Hiroe Tanaka, Masaaki Ryomoto, Shinya Fukui, Yoshiteru
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Objectives: It is well known that free radicals cause
reperfusion injury after leg ischemia. At Vascular Annual
Meeting 2010, our pathohistological study of Periodic
Acid Schiff staining showed that the free-radical scavenger,
edaravone (Radicut®, Mitsubishi Tanabe Pharma Co., Ja-
pan) suppressed reperfusion injury and maintained high
glycogen stores in lower extremity muscles. In the present
study, we used transmission electro microscope (TEM) to
elucidate how edaravone suppresses reperfusion injury.
Methods: Male Lewis rats (632  89 gm) were intra-
Fig. 1. Measurement of neointimal thickness (mm) by histomor-
phometry and representative images for BMS and DES at 3, 6 and
12 months post-implantation.peritoneally injected with edaravone (3.0 mg/kg, edara- oone group, n  3) or the same dose of saline (control
roup, n 3). Reperfusion injury models were induced by
lamping bilateral common femoral arteries for 5 hours and
hen de-clamping. At least 5 hours after reperfusion, the
ransverse sections of lower extremity muscles were imme-
iately made using a diamond knife. Under a TEM (JEM-
220, NipponDenshi Co., Japan), we counted the number
f glycogen-granules at 50,000x magnification on each 5
ifferent fields.
Results: The TEM sections from the control group
howed marked loss of glycogen-granules with swollen
itochondria. In contrast, the TEM sections from the
daravone group showed numerous glycogen-granules and
ormal mitochondria (Figure). The mean density of glyco-
en-granules in the edaravone group was significantly
igher than that in the control group (88.6  5.4 vs.
1.6  3.0 particles/m2, p  0.001).
Conclusions: Our TEM results confirmed that edara-
one suppresses reperfusion injury following leg ischemia
y maintaining the glycogen-granules in muscles.
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Objectives: Dermal fibroblasts are key cells in wound
ealing and remodeling by secreting MMP-2, MMP-9 and
GF-
. Patients with metabolic syndrome and diabetes
ith subsequent hyperglycemia are at increased risk of
mpaired wound healing. Although the effects of hypergly-
emia are well characterized in many different tissues, little
s known about the effects on dermal fibroblast function.
e hypothesize that hyperglycemia causes decreased rates
f proliferation and MMP-2, MMP-9 and TGF-
 secre-
